Name | Symbol | Markt | Aktientyp |
---|---|---|---|
SQZ Biotechnologies Company | SQZ | NYSE | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
0,435 | 0,435 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
23.1.2024 | 22:31 | EDGAR2 | Form DEFM14A - Definitive proxy statement relating to merger.. |
22.12.2023 | 23:18 | EDGAR2 | Form 8-K - Current report |
08.11.2023 | 22:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
15.9.2023 | 15:04 | EDGAR2 | Form 8-K - Current report |
25.7.2023 | 13:34 | EDGAR2 | Form 8-K - Current report |
07.7.2023 | 22:30 | EDGAR2 | Form 8-K - Current report |
03.7.2023 | 19:53 | EDGAR2 | Form 8-K - Current report |
15.6.2023 | 22:30 | BW | SQZ Biotechnologies to Consolidate Shares with 1-for-10.. |
10.5.2023 | 22:45 | BW | SQZ Biotechnologies Reports First Quarter 2023 Financial.. |